The Impact of Event Scale-Revised (IES-R) is a 22-item self-report measure designed to assess distress caused by a traumatic event and can assist clinicians in assessing for Post Traumatic Stress Disorder (PTSD). This technical review presents normative data from latent profile analysis of clinical populations, along with detailed percentile rankings and interpretive guidelines, to help clinicians better understand and utilise the assessment in practice.
The Impact of Event Scale-Revised (IES-R) is a 22-item self-report measure used to assess Post-Traumatic Stress Disorder (PTSD) symptoms in adults following exposure to a traumatic event (Weiss, 2007). The IES-R was developed as a revision of the original Impact of Event Scale (Horowitz et al., 1979) to align more closely with DSM criteria for PTSD by adding items that assess hyperarousal symptoms. The scale asks respondents to rate how distressing specific difficulties have been during the past seven days with respect to a particular traumatic event.
Post-traumatic stress disorder is characterised by persistent and distressing symptoms that develop following exposure to actual or threatened death, serious injury, or sexual violence (American Psychiatric Association, 2013). PTSD affects approximately 6-9% of individuals in their lifetime (Kessler et al., 2005). The disorder involves a complex constellation of symptoms that can significantly impair functioning across multiple life domains.
The IES-R comprises three subscales which assess three core symptom clusters of PTSD as conceptualised in DSM:
Research has consistently demonstrated that the IES-R correlates significantly with other measures of PTSD symptomatology, including the PTSD Checklist (PCL) and the Clinician-Administered PTSD Scale (CAPS) (Creamer et al., 2003). It has also shown strong associations with anxiety, depression, and overall psychological distress (Asukai et al., 2002). Studies have found that higher IES-R scores are associated with impaired immune system functioning, reduced quality of life, and increased risk for comorbid psychiatric disorders (Kawamura et al., 2001).
In clinical practice, the IES-R can be used in several ways to support assessment and care. First, it acts as an efficient screening tool to identify individuals who may require further comprehensive assessment for PTSD. This is particularly valuable because many trauma survivors may not spontaneously disclose their symptoms due to shame, avoidance, or lack of awareness that their experiences constitute clinical concerns (Loewenstein, 2018). Identifying which symptom clusters predominate for a given individual is also beneficial for case formulation and treatment planning. For example, someone with elevated intrusion symptoms might benefit from trauma-focused cognitive-behavioural therapy emphasising cognitive restructuring, whilst someone with pronounced avoidance might require gradual exposure-based interventions. The scale also serves as an outcome monitoring tool, allowing clinicians to track symptom changes over time and assess treatment efficacy. Given that the IES-R specifically asks about symptoms experienced in the past seven days, it can be administered at regular intervals to monitor symptom severity and change over time during trauma-focused treatment.
The scale is event-specific and requires that respondents have experienced and identified a particular traumatic event before completing the measure. Clinicians should establish that a traumatic event has occurred and clarify which specific event the client is rating if multiple traumas have been experienced. When interpreting very low scores, it is important to confirm whether the client is responding in relation to an actual traumatic event, as scores near zero could reflect either effective coping or the absence of a relevant traumatic experience to assess.
The IES-R produces a total score ranging from 0-88, with higher scores indicating a greater frequency and severity of post-traumatic stress symptoms. Three subscale scores with differing ranges are also produced:

The total score is also expressed as an average score from 0-4 (by taking the raw score and dividing it by the number of items), and as a percentile rank based on the sub-clinical profile from NovoPsych’s Latent Profile Analysis. This percentile contextualises the client’s score relative to treatment-seeking individuals who have been exposed to a traumatic event, and who have low symptoms or who are managing their symptoms well. For example, a client’s score at the 70th percentile means that 70% of individuals in the sub-clinical group scored lower, indicating the client has a higher level of trauma-related distress compared to their sub-clinical peers.
Severity ranges are given for the total score, with a total score exceeding 24 (average score 1.09: Average Likert score above “A little bit”) indicates PTSD symptoms are clinically relevant. A score of 33 or above (average score 1.50) represents an appropriate cut-off for probable PTSD. A score of 37 (average score 1.68) or more is indicative of severe symptoms that have been associated with significant functional impairment and physiological issues such as immunosuppression.
Severity descriptors for the total score are based on cut-off scores in the literature, detailed here:
For tracking clinical progress, changes of half a standard deviation (approximately 9 total score points) are considered clinically meaningful, following the minimally important difference guidelines (Norman et al., 2003; Turner et al., 2010). Monitoring scores over time allows clinicians to assess treatment effectiveness and adjust trauma-focused interventions as needed.
On first administration, results are shown in a stacked average score bar graph, which displays the total average score.

Then, a second bar graph of the three subscale average scores is shown next, allowing each symptom cluster’s relative contribution to overall distress to be seen.
A comparison graph is also presented showing the respondent’s raw score relative to a group of trauma-exposed but well coping individuals and a sample of patients with a confirmed PTSD diagnosis.
When administered multiple times, two line graphs are generated, the first tracks the total average score.
The second shows the subscale average scores over time to visualise changes in symptom patterns.
Severity ranges for the subscales use a gradient, with Likert response labels on the right for reference. Response table descriptors for the subscales also follow this logic:
Interpretation at the subscale level may also be clinically useful. For example, a high score on the Avoidance subscale relative to the Intrusion subscale may suggest that the client’s avoidance strategies may be temporarily ‘successful’ in keeping intrusive symptoms at bay. However, this avoidance pattern is likely impeding progress by preventing natural emotional processing of the trauma.
The IES-R demonstrates strong construct validity as a measure of post-traumatic stress symptoms. Convergent validity is supported by moderate to high correlations with other established PTSD measures. For example, Creamer et al. (2003) reported correlations of r = .84 with the PCL and r = .77 with the CAPS. The scale also shows theoretically consistent relationships with measures of anxiety (r = .66), depression (r = .60), and general psychological distress (r = .67) (Asukai et al., 2002). Discriminant validity has been established through the scale’s ability to distinguish between trauma-exposed individuals with and without PTSD diagnoses (Creamer et al., 2003).
The IES-R exhibits excellent internal consistency across multiple studies and populations. Cronbach’s alpha for the total score ranges from α = .92 to α = .96 (Asukai et al., 2002; Creamer et al., 2003; Weiss, 2007). The subscales also demonstrate good to excellent internal consistency: Intrusion (α = .87 to .94), Avoidance (α = .84 to .87), and Hyperarousal (α = .79 to .91) (Creamer et al., 2003; Weiss, 2007). Test-retest reliability over intervals of one to six months has been found to be good, with correlation coefficients ranging from r = .89 to r = .94 for the total score (Weiss, 2007).
Regarding dimensionality, factor analytic studies have consistently supported the three-factor structure corresponding to intrusion, avoidance, and hyperarousal symptoms. Confirmatory factor analyses have demonstrated that this three-factor model provides acceptable to good fit across diverse trauma-exposed samples (Asukai et al., 2002; Creamer et al., 2003). Alternative models, including a single-factor solution and a two-factor model, have been tested but generally show poorer fit compared to the three-factor structure. The three-factor model aligns with theoretical conceptualisations of PTSD symptomatology and has been replicated across multiple countries and cultural contexts, supporting it as the most empirically and clinically robust representation of the IES-R’s structure.
An important consideration highlighted by Weiss (2007) is that whilst PTSD diagnostic criteria were revised in the DSM-5 to separate avoidance and numbing criteria and increase the number of associated symptoms from 17 to 20, this revision does not fundamentally change the phenotype of PTSD. The IES-R continues to have utility in screening for PTSD symptoms despite not perfectly mapping onto DSM-5 criteria (Coffey & Berglind, 2006).
Clinical normative data for the IES-R were obtained from a sample of individuals with confirmed PTSD diagnoses (n = 71) reported by Rash et al. (2008). PTSD status was determined using structured diagnostic interviews and the CAPS to assess Criteria B-F. This sample was drawn from the United States and had a mean total IES-R score of 45.4 (SD = 17.8) and provides a clinical comparison for interpreting scores.
Community normative data for the IES-R present unique challenges because the scale is administered in relation to a specific traumatic event, making it difficult to establish a general population reference. Most normative data comes from trauma-exposed populations rather than general community samples. One study provided such a sample of (n = 999) general population respondents who completed the IES-R (Aljaberi et al., 2022). Their mean scores (M = 21.06, SD = 16.30) were comparably lower than a widely cited earlier sample of (n = 182) individuals involved in motor vehicle accidents (M = 34.98, SD = 19.80) (Beck et al., 2008). While this community sample was promising, it included no Western or predominantly English-speaking countries in its composition.
NovoPsych carried out a Latent Profile Analysis (LPA) to determine if a ‘sub-clinical’ subsample/latent profile existed within the wider clinical dataset (N = 10,560) composed of individuals who had completed the IES-R in therapeutic settings. LPA is a person-centred statistical approach that identifies distinct, latent subgroups within a population based on patterns of responses in combination with maximum likelihood estimation, and model fit indices such as Akaike and Bayesian Information Criterions (AIC/BIC), as well as likelihood ratio tests and entropy estimators. In other words, LPA is a statistical technique that looks for naturally occurring sub-groups of people based on how they answered the IES-R. Here, LPA allows for the potential extraction of meaningful comparison groups from real-world data. NovoPsych’s LPA analysis identified three distinct profiles: Sub-Clinical (M = 16.43, SD = 8.71), Clinical (M = 43.41, SD = 7.39), and Severe (M = 67.34, SD = 8.07). Notably, the sub-clinical profile extracted from NovoPsych data demonstrated a lower mean score than the normative sample reported by Aljaberi et al. (2022), suggesting it represents individuals who, despite being in clinical settings, are managing any trauma-related distress well and are thus an appropriate comparison group.
Cut-off scores for the total have been established based on research examining the relationship between IES-R scores and the presence or absence of a PTSD diagnosis. A score of 24 or above indicates that PTSD is a clinical concern, with those scoring in this range who do not have full PTSD likely experiencing some PTSD symptoms (Asukai et al., 2002). A score of 33 or above represents the optimal cut-off for probable PTSD diagnosis, providing the best balance between sensitivity and specificity (Creamer et al., 2003). Research has also found that scores of 37 or above are high enough to suppress immune system functioning, even 10 years after the traumatic event (Kawamura et al., 2001).
Based on cut-off scores provided in the literature (Asukai et al., 2002; Creamer et al., 2003; Kawamura et al., 2001), several severity categories are provided below to aid in the interpretation of the IES-R Total Score:
It’s entirely normal to experience distressing thoughts, emotions, and heightened alertness immediately following a traumatic event – this is part of the human stress response. The key difference lies in the persistence, intensity, and impact of these symptoms. Normal trauma responses typically diminish over weeks or months as the person processes the event and returns to daily functioning. Clinically significant PTSD symptoms, as measured by the IES-R, involve persistent intrusive memories, ongoing avoidance behaviors, and sustained hyperarousal that interfere with daily life for weeks or months after the event.
The IES-R’s three subscales – intrusion, avoidance, and hyperarousal – provide a profile of which symptom clusters are most prominent for an individual, which directly guides treatment selection. For example, someone with elevated intrusion symptoms (unwanted memories, nightmares, flashbacks) may benefit from trauma-focused cognitive-behavioral therapy or EMDR to process these intrusive memories. A person with pronounced avoidance patterns might require graduated exposure interventions to help them safely approach trauma-related stimuli they’ve been avoiding. Those with significant hyperarousal (sleep disturbances, irritability, concentration difficulties) may need physiological regulation techniques such as relaxation training, breathing exercises, or medication before engaging in trauma processing work.
PTSD symptoms measured by the IES-R frequently co-occur with other mental health conditions, particularly depression, anxiety disorders, and substance use disorders. Research shows correlations between IES-R scores and measures of depression, anxiety and general psychological distress. Trauma symptoms can contribute to depression through persistent negative thoughts and reduced activity, while hyperarousal symptoms often manifest as generalised anxiety. Some individuals may also use substances to manage intrusive symptoms or reduce hyperarousal.
Yes, the IES-R can track treatment progress over time, it specifically asks about symptoms during the past seven days. Changes of approximately 9 points (half a standard deviation) are considered clinically meaningful, providing a benchmark for evaluating whether treatment is effective. By administering the IES-R at regular intervals throughout trauma-focused therapy, clinicians can visualise symptom changes across the total score. This allows for adjustments to treatment approach, for example if intrusion symptoms decrease but avoidance remains high, the clinician might shift focus to exposure-based interventions. Regular monitoring also helps validate the client’s experience of improvement and can motivate continued engagement when progress is visible.
Weiss, D.S., & Marmar, C.R. (1997). The Impact of Event Scale-Revised. In J.P. Wilson, & T.M. Keane (Eds.), Assessing Psychological Trauma and PTSD: A Practitioner’s Handbook (pp. 399-411). New York: Guilford Press.
Aljaberi, M. A., Lee, K. H., Alareqe, N. A., Qasem, M. A., Alsalahi, A., Abdallah, A. M., Noman, S., Al-Tammemi, A. B., Mohamed Ibrahim, M. I., & Lin, C. Y. (2022). Rasch modeling and multilevel confirmatory factor analysis for the usability of the Impact of Event Scale-Revised (IES-R) during the COVID-19 pandemic. Healthcare, 10(10), 1858. https://doi.org/10.3390/healthcare10101858
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.
Asukai, N., Kato, H., Kawamura, N., Kim, Y., Yamamoto, K., Kishimoto, J., Miyake, Y., & Nishizono-Maher, A. (2002). Reliability and validity of the Japanese-language version of the Impact of Event Scale-Revised (IES-R-J): Four studies of different traumatic events. Journal of Nervous and Mental Disease, 190(3), 175-182. https://doi.org/10.1097/00005053-200203000-00006
Beck, J. G., Grant, D. M., Read, J. P., Clapp, J. D., Coffey, S. F., Miller, L. M., & Palyo, S. A. (2008). The impact of event scale-revised: Psychometric properties in a sample of motor vehicle accident survivors. Journal of Anxiety Disorders, 22(2), 187-198. https://doi.org/10.1016/j.janxdis.2007.02.007
Coffey, S. F., & Berglind, G. (2006). Screening for PTSD in motor vehicle accident survivors using PSS-SR and IES. Journal of Traumatic Stress, 19(1), 119-128. https://doi.org/10.1002/jts.20106
Creamer, M., Bell, R., & Failla, S. (2003). Psychometric properties of the Impact of Event Scale-Revised. Behaviour Research and Therapy, 41(12), 1489-1496. https://doi.org/10.1016/j.brat.2003.07.010
Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of Event Scale: A measure of subjective stress. Psychosomatic Medicine, 41(3), 209-218. https://doi.org/10.1097/00006842-197905000-00004
Kawamura, N., Yoshiharu, K., & Nozomu, A. (2001). Suppression of cellular immunity in men with a past history of post-traumatic stress disorder. American Journal of Psychiatry, 158(3), 484-486. https://doi.org/10.1176/appi.ajp.158.3.484
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593-602. https://doi.org/10.1001/archpsyc.62.6.593
Loewenstein, R. J. (2018). Dissociation debates: Everything you know is wrong. Dialogues in Clinical Neuroscience, 20(3), 229-242. https://doi.org/10.31887/DCNS.2018.20.3/rloewenstein
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582-592. https://doi.org/10.1097/01.MLR.0000062554.74615.4C
Rash, C. J., Coffey, S. F., Baschnagel, J. S., Drobes, D. J., & Saladin, M. E. (2008). Psychometric properties of the IES-R in traumatized substance dependent individuals with and without PTSD. Addictive Behaviors, 33(8), 1039-1047. https://doi.org/10.1016/j.addbeh.2008.04.006
Turner, D., Schünemann, H. J., Griffith, L. E., Beaton, D. E., Griffiths, A. M., Critch, J. N., & Guyatt, G. H. (2010). The minimal detectable change cannot reliably replace the minimal important difference. Journal of Clinical Epidemiology, 63(1), 28-36. https://doi.org/10.1016/j.jclinepi.2009.01.024
Weiss, D. S. (2007). The Impact of Event Scale-Revised. In J. P. Wilson & T. M. Keane (Eds.), Assessing psychological trauma and PTSD: A practitioner’s handbook (2nd ed., pp. 168-189). Guilford Press.